Evidence map›Paper›PMID 36636377›Full record

ReviewInfection and drug resistance2023

Is AMR in Dairy Products a Threat to Human Health? An Updated Review on the Origin, Prevention, Treatment, and Economic Impacts of Subclinical Mastitis.

Ragul Paramasivam, Dhinakar Raj Gopal, Ranjithkumar Dhandapani, Ramalakshmi Subbarayalu, Mahesh Prabu Elangovan, Bhavadharani Prabhu, Veeramani Veerappan, Arunkumar Nandheeswaran, Siddarth Paramasivam, Saravanan Muthupandian

Open access · goldAbstract readReview
In one paragraph

Review in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
23.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Phenotypic and Genomic Profiling ofAntibiotics (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  16. Article
  17. Review
  18. Kurarinone and sophoraflavanone G fromFrontiers in microbiology · 2026
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Ragul ParamasivamResearch and Development Division, Chimertech Private Limited, Chennai, India.
Dhinakar Raj GopalDepartment of Animal Biotechnology, Madras Veterinary College, Tamilnadu Veterinary and Animal Science University (TANUVAS), Chennai, 600007, India.
Ranjithkumar DhandapaniResearch and Development Division, Chimertech Private Limited, Chennai, India.
Ramalakshmi SubbarayaluResearch and Development Division, Chimertech Private Limited, Chennai, India.
Mahesh Prabu ElangovanResearch and Development Division, Chimertech Private Limited, Chennai, India.
Bhavadharani PrabhuResearch and Development Division, Chimertech Private Limited, Chennai, India.
Veeramani VeerappanResearch and Development Division, Chimertech Private Limited, Chennai, India.
Arunkumar NandheeswaranResearch and Development Division, Chimertech Private Limited, Chennai, India.
Siddarth ParamasivamResearch and Development Division, Chimertech Private Limited, Chennai, India.
Saravanan MuthupandianAMR and Nanotherapeutics Lab, Centre for Transdisciplinary Research (CFTR), Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India.ORCID 0000-0002-1480-3555
Mekelle University · ETTamil Nadu Veterinary and Animal Sciences University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bovine mastitis is the most frequent and costly illness impacting dairy herds worldwide. The presence of subclinical mastitis in dairy cows has an impact on the decreased output of milk and milk quality, culling of affected cows, mortality rate, as well as mastitis-related treatment expenses, generating significant financial loss to the dairy industry. The pathogenic bacteria invade through the mammary gland, which then multiply in the milk-producing tissues causing infection, and the presence of pathogenic bacteria in milk is concerning, jeopardizes human health, and also has public health consequences. Intervention to promote herd health is essential to protect public health and the economy. Results: This review attempts to provide an overview of subclinical mastitis, including mastitis in different species, the effect of mastitis on human health and its pathogenic mechanism, the prevalence and incidence of subclinical mastitis, and current preventive, diagnostic, and treatment methods for subclinical mastitis. It also elaborates on the management practices that should be followed by the farms to improve herd immunity and health. Conclusion: This review brings the importance of the threat of antimicrobial resistance organisms to the dairy industry. Furthermore, this review gives a glimpse of the economic consequences faced by the farmers and a futuristic mastitis market analysis in the dairy industry.

Indexed as

economyhuman healthmanagementpathogenic mechanismsubclinical mastitis

Identifiers

PMID36636377
PMCPMC9831082
OpenAlexW4313540542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.